Crown Laboratories Acquires Aesthetics Eclipse’s Aesthetics Portfolio
Skincare company Crown Laboratories has finalized an agreement to acquire the global, aesthetics-focused assets of medical technology company Eclipse.
Skincare company Crown Laboratories has finalized an agreement to acquire the global, aesthetics-focused assets of medical technology company Eclipse.
Brian Pilcher, PhD, discusses Conexeu’s CXU platform and what 3D-printed extracellular matrix technology could mean for future reconstructive and aesthetic surgery.